These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 23498552

  • 1. Assessment of the quality of publicly reported central line-associated bloodstream infection data in Colorado, 2010.
    Rich KL, Reese SM, Bol KA, Gilmartin HM, Janosz T.
    Am J Infect Control; 2013 Oct; 41(10):874-9. PubMed ID: 23498552
    [Abstract] [Full Text] [Related]

  • 2. Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.
    Oh JY, Cunningham MC, Beldavs ZG, Tujo J, Moore SW, Thomas AR, Cieslak PR.
    Infect Control Hosp Epidemiol; 2012 May; 33(5):439-45. PubMed ID: 22476268
    [Abstract] [Full Text] [Related]

  • 3. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Mar 04; 60(8):243-8. PubMed ID: 21368740
    [Abstract] [Full Text] [Related]

  • 4. Trends in validity of central line-associated bloodstream infection surveillance data, New York State, 2007-2010.
    Hazamy PA, Van Antwerpen C, Tserenpuntsag B, Haley VB, Tsivitis M, Doughty D, Gase KA, Tucci V, Stricof RL.
    Am J Infect Control; 2013 Dec 04; 41(12):1200-4. PubMed ID: 24035214
    [Abstract] [Full Text] [Related]

  • 5. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
    Worth LJ, Brett J, Bull AL, McBryde ES, Russo PL, Richards MJ.
    Am J Infect Control; 2009 Oct 04; 37(8):643-8. PubMed ID: 19589619
    [Abstract] [Full Text] [Related]

  • 6. Effect of 2013 National Healthcare Safety Network definition changes on central line bloodstream infection rates: audit results from the New York State Department of Health.
    Hazamy PA, Haley VB, Tserenpuntsag B, Tsivitis M, Giardina R, Knab R, Lutterloh E.
    Am J Infect Control; 2015 Mar 01; 43(3):280-2. PubMed ID: 25556048
    [Abstract] [Full Text] [Related]

  • 7. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.
    Tedja R, Gordon SM, Fatica C, Fraser TG.
    Infect Control Hosp Epidemiol; 2014 Feb 01; 35(2):164-8. PubMed ID: 24442079
    [Abstract] [Full Text] [Related]

  • 8. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition.
    See I, Iwamoto M, Allen-Bridson K, Horan T, Magill SS, Thompson ND.
    Infect Control Hosp Epidemiol; 2013 Aug 01; 34(8):769-76. PubMed ID: 23838215
    [Abstract] [Full Text] [Related]

  • 9. Validation of central line-associated bloodstream infection data in a voluntary reporting state: New Mexico.
    Thompson DL, Makvandi M, Baumbach J.
    Am J Infect Control; 2013 Feb 01; 41(2):122-5. PubMed ID: 23040607
    [Abstract] [Full Text] [Related]

  • 10. Surveillance Provinciale des Infections Nosocomiales (SPIN) Program: implementation of a mandatory surveillance program for central line-associated bloodstream infections.
    Fontela PS, Platt RW, Rocher I, Frenette C, Moore D, Fortin É, Buckeridge D, Pai M, Quach C.
    Am J Infect Control; 2011 May 01; 39(4):329-35. PubMed ID: 21255873
    [Abstract] [Full Text] [Related]

  • 11. Device-associated nosocomial infection rates in intensive care units at Cairo University hospitals: first step toward initiating surveillance programs in a resource-limited country.
    El-Kholy A, Saied T, Gaber M, Younan MA, Haleim MM, El-Sayed H, El-Karaksy H, Bazara'a H, Talaat M.
    Am J Infect Control; 2012 Aug 01; 40(6):e216-20. PubMed ID: 22418610
    [Abstract] [Full Text] [Related]

  • 12. Device-associated infection rates, device use, length of stay, and mortality in intensive care units of 4 Chinese hospitals: International Nosocomial Control Consortium findings.
    Hu B, Tao L, Rosenthal VD, Liu K, Yun Y, Suo Y, Gao X, Li R, Su D, Wang H, Hao C, Pan W, Saunders CL.
    Am J Infect Control; 2013 Apr 01; 41(4):301-6. PubMed ID: 23040491
    [Abstract] [Full Text] [Related]

  • 13. Validation of the surveillance and reporting of central line-associated bloodstream infection data to a state health department.
    Backman LA, Melchreit R, Rodriguez R.
    Am J Infect Control; 2010 Dec 01; 38(10):832-8. PubMed ID: 21093699
    [Abstract] [Full Text] [Related]

  • 14. Central line-associated bloodstream infection rate elevation: Attributable to National Healthcare Safety Network surveillance definition changes, ongoing opportunities for infection prevention, or both?
    Corley A, Cantara M, Gardner J, Trexler P, Rock C, Maragakis LL.
    Am J Infect Control; 2017 Sep 01; 45(9):1030-1032. PubMed ID: 28736032
    [Abstract] [Full Text] [Related]

  • 15. Utilizing a line maintenance team to reduce central-line-associated bloodstream infections in a neonatal intensive care unit.
    Holzmann-Pazgal G, Kubanda A, Davis K, Khan AM, Brumley K, Denson SE.
    J Perinatol; 2012 Apr 01; 32(4):281-6. PubMed ID: 22011970
    [Abstract] [Full Text] [Related]

  • 16. Epidemiology of central line-associated bloodstream infections in Quebec intensive care units: a 6-year review.
    Fontela PS, Platt RW, Rocher I, Frenette C, Moore D, Fortin E, Buckeridge D, Pai M, Quach C.
    Am J Infect Control; 2012 Apr 01; 40(3):221-6. PubMed ID: 21824682
    [Abstract] [Full Text] [Related]

  • 17. Reducing central line-associated bloodstream infections in North Carolina NICUs.
    Fisher D, Cochran KM, Provost LP, Patterson J, Bristol T, Metzguer K, Smith B, Testoni D, McCaffrey MJ.
    Pediatrics; 2013 Dec 01; 132(6):e1664-71. PubMed ID: 24249819
    [Abstract] [Full Text] [Related]

  • 18. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies.
    Digiorgio MJ, Fatica C, Oden M, Bolwell B, Sekeres M, Kalaycio M, Akins P, Shane C, Bako J, Gordon SM, Fraser TG.
    Infect Control Hosp Epidemiol; 2012 Sep 01; 33(9):865-8. PubMed ID: 22869258
    [Abstract] [Full Text] [Related]

  • 19. Evaluating application of the National Healthcare Safety Network central line-associated bloodstream infection surveillance definition: a survey of pediatric intensive care and hematology/oncology units.
    Gaur AH, Miller MR, Gao C, Rosenberg C, Morrell GC, Coffin SE, Huskins WC.
    Infect Control Hosp Epidemiol; 2013 Jul 01; 34(7):663-70. PubMed ID: 23739069
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.